{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:58:06Z","timestamp":1648814286324},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T00:00:00Z","timestamp":1602115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00192-020-04553-5","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T10:03:06Z","timestamp":1602151386000},"page":"261-265","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Female pelvic medicine & reconstructive surgery (FPMRS) challenges on behalf of the collaborative research in pelvic surgery consortium (CoRPS): managing complicated cases series 7: can fibroids worsen incontinence?"],"prefix":"10.1007","volume":"32","author":[{"given":"Sarah J.","family":"Weingarten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Digesu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynsey","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanaka","family":"Dune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladin A.","family":"Yurteri-Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Weber LeBrun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"Grimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,8]]},"reference":[{"issue":"1","key":"4553_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0015-0282(02)04539-9","volume":"79","author":"G Pron","year":"2003","unstructured":"Pron G, Cohen M, Soucie J, Garvin G, Vanderburgh L, Bell S, et al. The Ontario uterine fibroid embolization trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. Fertil Steril. 2003;79(1):112\u20139.","journal-title":"Fertil Steril"},{"key":"4553_CR2","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/nau.23541","volume":"37.6","author":"S Houlihan","year":"2018","unstructured":"Houlihan S, Koenig N, Friedman B, Lee T, Geoffrion. Fibroid surgery and improvement in bladder symptoms: the FAB study. Neurourol Urodyn. 2018;37.6:1965\u201370.","journal-title":"Neurourol Urodyn"},{"key":"4553_CR3","first-page":"133","volume":"28","author":"S Houlihan","year":"2017","unstructured":"Houlihan S, Hyakutake MT, Koenig NA, Lee T, Geoffrion R. Debulking surgery for fibroids and the impact on bladder symptoms. Int J Urogyn. 2017;28:133\u20134.","journal-title":"Int J Urogyn"},{"issue":"2","key":"4553_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/SPV.0b013e31820c99a9","volume":"17","author":"C Parker-Autry","year":"2011","unstructured":"Parker-Autry C, Harvie H, Arya LA, Northington GM. Lower urinary tract symptoms in patients with uterine fibroids: association with fibroid location and uterine volume. Female Pelvic Med Reconstr Surg. 2011;17(2):91\u20136.","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"4553_CR5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","volume":"124","author":"EA Stewart","year":"2017","unstructured":"Stewart EA, Cookson C, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124:1501\u201312.","journal-title":"BJOG"},{"key":"4553_CR6","volume-title":"Williams gynecology","author":"JO Schorge","year":"2008","unstructured":"Schorge JO, Williams JW. Williams gynecology. Texas: McGraw-Hill; 2008."},{"key":"4553_CR7","volume-title":"Operative gynecology","author":"RW Te Linde","year":"1970","unstructured":"Te Linde RW, Mattingly RF. Operative gynecology. Philadelphia: JB Lippincott; 1970."},{"key":"4553_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/aje\/kwk018","volume":"165.3","author":"LE Waetjen","year":"2006","unstructured":"Waetjen LE, Liao S, Johnson WO, Sampselle CM, Sternfield B, Harlow SD, et al. Factors associated with prevalent and incident urinary incontinence in a cohort of midlife women: a longitudinal analysis of data: study of women\u2019s health across the nation. Am J Epidemiol. 2006;165.3:309\u201318.","journal-title":"Am J Epidemiol"},{"key":"4553_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0002-9378(90)90672-T","volume":"163.4","author":"R Langer","year":"1990","unstructured":"Langer R, Golan A, Neuman M, Schneider D, Bukovsky I, Caspi E. The effect of large uterine fibroids on urinary bladder function and symptoms. Am J Obstet Gynecol. 1990;163.4:1139\u201341.","journal-title":"Am J Obstet Gynecol"},{"key":"4553_CR10","first-page":"53","volume":"216.1","author":"KS Bohlin","year":"2017","unstructured":"Bohlin KS, Ankardal M, Lindkvist H, Milsom I. Factors influencing the incidence and remission of urinary incontinence after hysterectomy. Am J Obstet Gynecol. 2017;216.1:53\u2013e1.","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04553-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04553-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T13:41:54Z","timestamp":1633700514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04553-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4553"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04553-5","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,8]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C Grimes: Expert witness, Johnson and Johnson, Consultant, Provepharm, Inc.L Hayward: International Urogynecological Board Member.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}